Apaziquone for Nonmuscle Invasive Bladder Cancer: Where Are We Now?
Urol Clin North Am
; 47(1): 73-82, 2020 Feb.
Article
en En
| MEDLINE
| ID: mdl-31757302
ABSTRACT
Apaziquone is an interesting drug for intravesical use in patients with nonmuscle invasive bladder cancer; however, more research is needed to prove its actual benefit. Although the apaziquone trials demonstrate the potential of this new drug, the singular phase 3 trials did not reach their primary endpoint. To date, no new trials are recruiting, so the development of apaziquone seems to have stopped.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Aziridinas
/
Neoplasias de la Vejiga Urinaria
/
Carcinoma de Células Transicionales
/
Indolquinonas
Límite:
Humans
Idioma:
En
Revista:
Urol Clin North Am
Año:
2020
Tipo del documento:
Article
País de afiliación:
Países Bajos